NBIX – neurocrine biosciences, inc. (US:NASDAQ)
Stock Stats
News
1/26
08:42 am
nbix
Medium
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1065890 in Adults with Tardive Dyskinesia [Yahoo! Finance]
1/26
08:30 am
nbix
Medium
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1065890 in Adults with Tardive Dyskinesia
1/23
02:41 pm
nbix
Low
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at UBS Group AG from $188.00 to $178.00. They now have a "buy" rating on the stock.
1/22
01:42 pm
nbix
Low
Can Neurocrine (NBIX) Keep the Earnings Surprise Streak Alive? [Yahoo! Finance]
1/21
04:19 pm
nbix
Low
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2025 Financial Results [Yahoo! Finance]
10/28/2025
04:01 pm
nbix
-6.4%
BEAT
7/30/2025
04:01 pm
nbix
-6.2%
BEAT
5/5/2025
04:01 pm
nbix
8.4%
BEAT
2/6/2025
04:01 pm
nbix
-18.5%
BEAT
1/23
02:34 pm
Maintains
Buy
Buy
UBS
Low
-0.9%
1/12
01:14 pm
Maintains
Overweight
Overweight
JP Morgan
Low
0.1%
1/8
08:02 am
Reiterates
Overweight
Equal Weight
Morgan Stanley
Low
-2.6%
1/8
08:02 am
Reiterates
Overweight
Equal Weight
Morgan Stanley
Low
-2.6%
1/8
07:15 am
Downgrades
Overweight
Equal-Weight
Morgan Stanley
Low
-3.0%
2/3
06:23 pm
nbix
Low
Form 4 NEUROCRINE BIOSCIENCES For: Jan 31 Filed by: Boyer David W.
2/3
06:22 pm
nbix
Low
Form 4 NEUROCRINE BIOSCIENCES For: Jan 31 Filed by: BENEVICH ERIC
2/3
06:06 pm
nbix
Low
Form 4 NEUROCRINE BIOSCIENCES For: Jan 31 Filed by: ABERNETHY MATT
2/3
06:05 pm
nbix
Low
Form 4 NEUROCRINE BIOSCIENCES For: Jan 31 Filed by: Cooke Julie
2/3
06:05 pm
nbix
Low
Form 4 NEUROCRINE BIOSCIENCES For: Jan 31 Filed by: Delaet Ingrid
Show more
Top News Gainers
7/29 Q2/2019 6/30/2019 EPS 0.540 ZacksConsensus 0.270 ActVsEst 0.270 - Beat 10.3%
11/8 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 7.4%
5/29 Form 4 NEUROCRINE BIOSCIENCES For: May 24 Filed by: Bozigian Haig P. 5.2%
3/25 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 4.6%
4/17 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 3.9%
8/8 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.6%
10/16 Form 4 NEUROCRINE BIOSCIENCES For: Oct 14 Filed by: Lloyd-Smith Malcolm 3.3%
7/8 Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2019 Financial Results 3.2%
5/7 Neurocrine Biosciences to Present at Bank of America Merrill Lynch Health Care Conference 2019 3.0%
1/28 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 3.0%
Top News Decliners
1/10 Form 4 NEUROCRINE BIOSCIENCES For: Jan 08 Filed by: ROBERTS EIRY -8.1%
7/31 Form 4 NEUROCRINE BIOSCIENCES For: Jul 30 Filed by: Bozigian Haig P. -4.5%
4/30 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "buy" rating re-affirmed by analysts at William Blair. -3.8%
2/24 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at William Blair. They set an "outperform" rating on the stock. -3.8%
6/4 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock. -3.7%
5/17 Form 3 NEUROCRINE BIOSCIENCES For: May 07 Filed by: Cooke Julie -3.3%
4/30 Form 4 NEUROCRINE BIOSCIENCES For: Apr 28 Filed by: ABERNETHY MATT -3.3%
4/27 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. -3.0%
2/4 Q4/2019 12/31/2019 EPS 1.050 ZacksConsensus 0.820 ActVsEst 0.230 - Beat -2.9%
8/8 Form 4 NEUROCRINE BIOSCIENCES For: Aug 06 Filed by: GORMAN KEVIN CHARLES -2.4%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3